Syringaresinol

CAS No. 487-35-4

Syringaresinol ( )

Catalog No. M31195 CAS No. 487-35-4

Syringaresinol is a lignan extracted from the sap of Lobelia longifolia with anti-inflammatory activity. syringaresinol causes vasodilation and enhances NO production through phosphorylation and dimerization of endothelial NO synthase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 288 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Syringaresinol
  • Note
    Research use only, not for human use.
  • Brief Description
    Syringaresinol is a lignan extracted from the sap of Lobelia longifolia with anti-inflammatory activity. syringaresinol causes vasodilation and enhances NO production through phosphorylation and dimerization of endothelial NO synthase.
  • Description
    Syringaresinol is a lignan extracted from the sap of Lobelia longifolia with anti-inflammatory activity. syringaresinol causes vasodilation and enhances NO production through phosphorylation and dimerization of endothelial NO synthase. Syringaresinol is a potential compound for the treatment of cancer and ischaemia-related diseases, inducing cardiomyocyte damage and death by activating FOXO3 to degrade HIF-1α±.
  • Synonyms
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    487-35-4
  • Formula Weight
    418.4
  • Molecular Formula
    C22H26O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Obtucarbamate B

    Obtucarbamate B has antitussive activity.

  • Isovanillic acid

    Isovanillic acidis is a natural product isolated from Senecio scandens and shows distinct anti -inflammatory activities.

  • XL413 (hydrochloride...

    XL413 inhibits the growth of MDA-MB-231T and COLO 205 cells (IC50s = 118 and 140 nM, respectively) and reduces tumor growth in a COLO 205 mouse xenograft model.